drugset / Trial / NCT03482037
Effects of Rec 0/0438 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury
RandomizedSequentialTriple-blindTreatment
Summary
Study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of Rec 0/0438 in subjects with neurogenic detrusor overactivity due to spinal cord injury
Timeline
- Start
- 2018-06-07
- Primary completion
- 2019-03-27
- Completion
- 2019-03-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rec 0/0438 | Unknown | 1 mg | Other |
| Subject | Rec 0/0438 | Unknown | 2 mg | Other |